Cargando…
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
Globally, more than 10 million people developed active tuberculosis (TB), with 1.4 million deaths in 2020. In addition, the emergence of drug-resistant strains in many regions of the world threatens national TB control programs. This requires an understanding of host-pathogen interactions and findin...
Autores principales: | Guler, Reto, Ozturk, Mumin, Sabeel, Solima, Motaung, Bongani, Parihar, Suraj P., Thienemann, Friedrich, Brombacher, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563828/ https://www.ncbi.nlm.nih.gov/pubmed/34745105 http://dx.doi.org/10.3389/fimmu.2021.733853 |
Ejemplares similares
-
Protocol for systematic review and meta-analysis: impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases
por: Sabeel, Solima, et al.
Publicado: (2020) -
Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice
por: Jones, Shelby-Sara, et al.
Publicado: (2022) -
IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice
por: Parihar, Suraj P., et al.
Publicado: (2021) -
Evaluation of Berberine as an Adjunct to TB Treatment
por: Ozturk, Mumin, et al.
Publicado: (2021) -
Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice
por: Parihar, Suraj P., et al.
Publicado: (2016)